While it ensures direct systemic absorption, it is less patient-friendly and may result in reduced treatment adherence
Cancer Res 82:CT108CT108 Schuhmacher J, Heidu S, Balchen T, Richardson JR, Schmeltz C, Sonne J, Schweiker J, Rammensee HG, Thor Straten P et al (2020) Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
It is studied as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme linked to metabolic and oncogenic pathways in research models
refrigerate or freeze for long-term research use Intended Use : In vitro assays, animal model studies, regenerative medicine research only This BPC-157 TB-500 10mg blend is supplied exclusively for laboratory research to support investigations into peptide-mediated healing, angiogenesis, and tissue regeneration